Sector: Pharmaceuticals

Even though the applicants were the first to extract and exploit IP-PA1, it did not necessarily follow that they should obtain trademark protection over the term. 

21 June 2024

The decision highlights the importance of considering implied – as well as express – comparisons when deploying comparative advertising. 

14 June 2024

These decisions are the first by national courts to interpret the CJEU’s preliminary ruling in Joined Cases C‑253/20 and C‑254/20.

13 June 2024

The input from trademark practitioners in this survey form is essential to capture an accurate representation of the current IP environment around the world.

03 June 2024

The burden of proving trademark infringement is lighter in cases involving medicinal drugs - especially Schedule-H drugs, which can be sold only by medical prescription. 

03 June 2024

The court found that the defendants’ use of the mark VIGOURA in relation to homeopathic medicine amounted to infringement and passing off of Pfizer’s registered mark VIAGRA.

30 May 2024

In this dispute over use of the ENERZY mark for an energy powder, the court had to interpret an agreement entered into by the parties in relation to the transfer of various trademarks upon payment of the agreed consideration. 

28 May 2024

With the clock ticking, we urge all IP professionals to contribute to the inaugural collaboration between WTR and IAM – the Global IP Benchmarking Survey.

27 May 2024

Among those honoured at this year's WTR Industry Awards were the trademark teams from adidas, Fanatics, Harley-Davidson, Jack Daniel’s and Yum! Brands.

22 May 2024

The difference at the beginning of the marks was not sufficient to outweigh the visual similarity produced by the common group of letters ‘erla’ and would not preclude the relevant public from perceiving that common sequence. 

16 May 2024